Cell And Gene Therapy Market Trends Include CAR T-Cell Therapy

(IT-NEWSWIRE.COM, July 08, 2021 ) Chimeric antigen receptor (CAR) T-cell therapy is increasingly gaining traction. In CAR T -cell therapy, T cells are collected from the patient’s blood and are genetically engineered to produce modified receptors at their surface, known as chimeric antigen receptors (CARs). These modified T cells with special structures (receptors) are then reinfused into the patient. These modified receptors of T cell help in targeting the surface antigen of the cancer cell t and in turn result in the killing of tumor cells in patients. In 2020, the US-FDA approved Bristol-Myers Squibb’s two CAR-T cell therapies to treat lymphoma and multiple myeloma. FDA approved CAR-T cells therapy treatments like Tisagenlecleucel for the treatment of B-cell precursor acute lymphoblastic leukemia (ALL) in children and Axicabtagene ciloleucel for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

The cell and gene therapy market consist of sales of cell and gene therapies by entities (organizations, sole traders and partnerships) that develop cell and gene therapies. Cell therapy refers to the transfer of intact, live cells that are originated from autologous or allogenic sources and gene therapy refers to the introduction, removal, or change in the genome for treating diseases. The market consists of revenue generated by the companies developing cell and gene therapy products by the sales of these products.

Cell And Gene Therapy Market Report Segments:

1) By Product: Cell Therapy, Gene Therapy

2) By Application: Oncology, Dermatology, Musculoskeletal, Others

3) By End User: Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Others

Read More On The Global Cell And Gene Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-market

Cell And Gene Therapy Market Size Forecast:

The global cell and gene therapy market is expected to grow from $6.69 billion in 2020 to $7.96 billion in 2021 at a compound annual growth rate (CAGR) of 19%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The cell and gene therapy market is expected to reach $17.32 billion in 2025 at a CAGR of 21%.

Major Players in the Cell And Gene Therapy Market:

Biogen Inc.

Novartis AG

Gilead Sciences

Ionis Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

Request For A Sample:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4058&type=smp

Cell And Gene Therapy Market - Opportunities And Strategies – Global Forecast To 2030 is one of a series of new reports from The Business Research Company that provide market overviews, analyze and forecast market size and growth for the whole market, cell and gene therapy market segments and geographies, cell and gene therapy market trends, drivers, restraints, leading competitors’ revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.

The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Reports Similar To The Cell And Gene Therapy Global Market Report By The Business Research Company:

Induced Pluripotent Stem Cell (IPSC) Global Market Report 2021: COVID-19 Growth And Change To 2030

https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-ipsc-global-market-report

Stem Cell/Cord Blood Banking Global Market Report 2021: COVID-19 Growth And Change To 2030

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Cell Based Assays Global Market Report 2021: COVID-19 Growth And Change To 2030

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Interested to know more about The Business Research Company?

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

The Business Research Company

Email: info@tbrc.info

Follow us on LinkedIn: https://bit.ly/3b7850r

Follow us on Twitter: https://bit.ly/3b1rmjS

Check out our Blog: http://blog.tbrc.info/

The Business Research Company

Marketing TBRC

+1 3156230293

Marketing@tbrc.info

Source: EmailWire.Com

Source: EmailWire.com

Technology News & Search Engine

Cell And Gene Therapy Market Trends Include CAR T-Cell Therapy